Brincidofovir Patent Expiration

Brincidofovir is Used for treating human smallpox disease. It was first introduced by Emergent Biodefense Operations Lansing Llc in its drug Tembexa on Jun 4, 2021.


Brincidofovir Patents

Given below is the list of patents protecting Brincidofovir, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Tembexa US10112909 Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof Oct 10, 2034 Emergent Biodefense
Tembexa US10487061 Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof Oct 10, 2034 Emergent Biodefense
Tembexa US8962829 Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof Oct 10, 2034 Emergent Biodefense
Tembexa US9303051 Phosphonate ester derivatives and methods of synthesis thereof Aug 31, 2031 Emergent Biodefense
Tembexa US9303051 Phosphonate ester derivatives and methods of synthesis thereof Aug 31, 2031 Emergent Biodefense
Tembexa US9371344 Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof Oct 10, 2034 Emergent Biodefense


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳